A landmark bill that seeks to legalize the possession of psychedelic substances in California is now due to be reviewed by the State Senate after clearing a major procedural...
Recent efforts to legalize psychedelics for medical and recreational purposes have intensified after the legalization of drugs under Schedule I controlled substances designated by the Controlled Substances Act of...
Vancouver-based clinical-stage pharmaceutical company Algernon Pharmaceuticals was recently added to the Horizons Psychedelic Stock Index ETF (PSYK) in the index’s first quarterly rebalance of holdings for 2021. PSYK is...
German biotech company Atai Life Sciences is all set to become one of the first licensed producers of psilocybin and other psychoactive medicinal substances in the U.S. Atai aims...
By late 2021, Numinus Bioscience plans to add 7,500 square feet to their state-of-the-art lab in Nanaimo BC in order to accelerate intellectual property development and to increase psychedelic supply capacity....
In a press release dated March 23rd, 2021, UK company COMPASS Pathways announced two new US patents related to the formulation and administration of the psychedelic compound psilocybin for...
On 20th January, MindMed, a premier psychedelic & biotech company, announced the start of the first-ever clinical trial that will measure and evaluate the combination of MDMA and LSD...
Canada's booming cannabis and psychedelic market are starting to make waves across the border. With the SAFE law about to be implemented, it is now easier for psychedelic medicine...
Toronto-based company Red Light Holland announced on March 19th, 2021, that its wholly-owned subsidiary, RLH Netherlands B.V. has successfully purchased SR Wholesale B.V., "one of the Netherlands' premiere distributors...
Bloom Burton Securities Inc. conducted the Offering (the "Lead Underwriter"), as lead underwriter and sole bookrunner with Stifel GMP and Canaccord Genuity Corp., forming a syndicate of underwriters (together...
